Unfortunately for us shareholders Stockrock, it is highly relevant that you have pointed out that the Phase2 trial recruitment has been painfully slow. It will unlikely be fully recruited by the end of 2019 CY at the rate they are going...
Ann: Starpharma commences phase 1/2 DEP irinotecan trial, page-22
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.7¢ |
Change
-0.003(3.00%) |
Mkt cap ! $40.48M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.5¢ | 9.7¢ | $111.3K | 1.115M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 43696 | 9.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 130967 | 1 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| SPL (ASX) Chart |